Fernando Clark spent the last 10 months of his life in an Alabama jail cell, waiting for court-ordered psychiatric treatment ...

It’s about how ADHD symptoms impact on your day-to-day functioning. Here’s how clinicians assess this, and where people might ...

JAY GLAZER, one of the biggest personalities in sports broadcasting, has built a career around high energy and quick delivery. Whether breaking major stories on live TV or doing exclusive interviews ...

Caplyta, the crown jewel of Johnson & Johnson's $14.6 billion buyout of Intra-Cellular Therapies, won the FDA’s blessing to ...

Adoptees’ higher ADHD rates reflect genetic, prenatal, and social factors, highlighting the need for trauma-informed, adoption-competent care and systemic equity.

There is no clear dividing line between those who are diagnosed with ADHD and those who are not since ADHD—much like blood pressure—occurs on a spectrum.

The U.S. Food and Drug Administration has approved the expanded use of Johnson & Johnson's drug Caplyta as an add-on treatment for adults with major depressive disorder, the company said on Thursday.

Lumateperone is approved as an adjunctive treatment for MDD, expanding its indications beyond schizophrenia and bipolar ...

Adhd is one of the most common psychiatric diagnoses in adults that affects approximately 1 in 16 adults and 1 in 10 children in the u.S.However, adhd symptoms ...

WASHINGTON -- Daily treatment with the investigational oral agent HU6 reduced liver fat and body weight without muscle loss in patients with metabolic dysfunction-associated steatohepatitis (MASH), ...

Attention deficit hyperactivity disorder, or ADHD, is a long-term neurodevelopmental disorder usually found and diagnosed in ...